Citation: | PU Zhiqiang, MAI Chao, MOU Tianyi, ZENG Jianhui. Relationships between serum high mobility group protein B1, soluble triggering receptor expressed on myeloid cells-like transcript 1 and acute lung injury induced by sepsis[J]. Journal of Clinical Medicine in Practice, 2021, 25(24): 97-100. DOI: 10.7619/jcmp.20212361 |
[1] |
邓梦芸, 史清海, 胡慧婷, 等. HMGB1和sCD14在脓毒症进展中的作用及临床应用价值[J]. 西北国防医学杂志, 2019, 40(2): 67-71. https://www.cnki.com.cn/Article/CJFDTOTAL-XBGY201902002.htm
|
[2] |
陈艳青, 黄潇, 孔桂青, 等. HMGB1和vWF等细胞因子对脓毒症患者病情严重程度及预后评估的意义[J]. 中华危重病急救医学, 2020, 32(8): 933-937. doi: 10.3760/cma.j.cn121430-20200428-00346
|
[3] |
MANFREDI B, MORALES-ORTÍZ J, DÍAZ-DÍAZ L M, et al. The characterization of monoclonal antibodies to mouse TLT-1 suggests that TLT-1 plays a role in wound healing[J]. Monoclon Antib Immunodiagn Immunother, 2018, 37(2): 78-86. doi: 10.1089/mab.2017.0063
|
[4] |
SINGER M, DEUTSCHMAN C S, SEYMOUR C W, et al. The third international consensus definitions for Sepsis and septic shock (Sepsis-3)[J]. JAMA, 2016, 315(8): 801-810. doi: 10.1001/jama.2016.0287
|
[5] |
中华医学会重症医学分会. 急性肺损伤/急性呼吸窘迫综合征诊断与治疗指南(2006)[J]. 中华内科杂志, 2007, 46(5): 430-435. doi: 10.3760/j.issn:0578-1426.2007.05.037
|
[6] |
ANDERSSON U, YANG H, HARRIS H. Extracellular HMGB1 as a therapeutic target in inflammatory diseases[J]. Expert Opin Ther Targets, 2018, 22(3): 263-277. doi: 10.1080/14728222.2018.1439924
|
[7] |
YANG H, WANG H, ANDERSSON U. Targeting inflammation driven by HMGB1[J]. Front Immunol, 2020, 11: 484. doi: 10.3389/fimmu.2020.00484
|
[8] |
王立鹤, 田小溪, 付国强, 等. 脓毒症患者血清miR-205和HMGB1的表达关系及意义[J]. 临床急诊杂志, 2020, 21(4): 287-291. https://www.cnki.com.cn/Article/CJFDTOTAL-ZZLC202004006.htm
|
[9] |
崔文娟, 李亚红, 胡国鑫, 等. 脓毒症合并急性肾损伤患者外周血TLR4、HMGB1、MFG-E8表达水平及临床意义[J]. 实用医学杂志, 2019, 18(7): 1116-1119, 1123. doi: 10.3969/j.issn.1006-5725.2019.07.023
|
[10] |
WANG J, LI R, PENG Z, et al. HMGB1 participates in LPS?induced acute lung injury by activating the AIM2 inflammasome in macrophages and inducing polarization of M1 macrophages via TLR2, TLR4, and RAGE/NF-κB signaling pathways[J]. Int J Mol Med, 2020, 45(1): 61-80. http://www.ingentaconnect.com/content/sp/ijmm/2020/00000045/00000005/art00033
|
[11] |
LI N, LIU X X, HONG M, et al. Sodium butyrate alleviates LPS-induced acute lung injury in mice via inhibiting HMGB1 release[J]. Int Immunopharmacol, 2018, 56: 242-248. doi: 10.1016/j.intimp.2018.01.017
|
[12] |
FU R, SONG X, SU D, et al. Serum STLT-1 and bilirubin levels in patients with acute coronary syndrome and correlation with prognosis[J]. Exp Ther Med, 2018, 16(1): 241-245. doi: 10.3892/etm.2018.6137/download
|
[13] |
SHEN L, YANG T, XIA K, et al. P-selectin (CD62P) and soluble TREM-like transcript-1(sTLT-1) are associated with coronary artery disease: a case control study[J]. BMC Cardiovasc Disord, 2020, 20(1): 387. doi: 10.1186/s12872-020-01663-2
|
[14] |
MORALES-ORTÍZ J, DEAL V, REYES F, et al. Platelet-derived TLT-1 is a prognostic indicator in ALI/ARDS and prevents tissue damage in the lungs in a mouse model[J]. Blood, 2018, 132(23): 2495-2505. doi: 10.1182/blood-2018-03-841593
|